Form 8-K · Current report
Linde plc 8-K, filed Jul 31, 2026
- Filed
- CIK
- 0001707925
- Accession no.
- 0001654954-26-007052
Summary
Linde plc reported second-quarter 2026 sales of $9.3 billion, up 9% year over year, adjusted operating profit of $2.7 billion (29.5% margin) and adjusted diluted EPS of $4.50, up 10%, and guided full-year 2026 adjusted EPS to $17.70–$17.90, representing 8%–9% growth. CEO Sanjiv Lamba said the company signed another long-term electronics supply contract in the U.S., lifting the sale-of-gas backlog to a record $8.1 billion.
Key points
- Second-quarter sales were $9,289 million, up 9% versus prior year, with underlying sales up 4% on 2% price and 2% volume growth.
- Operating cash flow was $2,271 million and free cash flow $833 million after capital expenditures of $1,438 million; $1,590 million was returned to shareholders through dividends and net repurchases.
- APAC sales rose 13% to $1,870 million, Americas sales rose 7% to $4,083 million, and EMEA sales rose 7% to $2,303 million.
- Third-quarter 2026 adjusted EPS guidance was set at $4.45 to $4.55, with full-year capital expenditures expected between $5.5 billion and $6.0 billion.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
ITEM 2.02 Results of Operations and Financial Condition On July 31, 2026, Linde plc issued a press release setting forth Linde plc’s results of operations for the quarter ended June 30, 2026. A copy of Linde plc’s press release is furnished herewith as Exhibit 99.1 and is hereby incorporated by reference in this Item 2.02. ITEM 9.01. Financial Statements and Exhibits. (d) Exhibits. The following exhibit is furnished herewith pursuant to Item 2.02 hereof: Exhibit No. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.